Literature DB >> 11255011

MMP-28, a new human matrix metalloproteinase with an unusual cysteine-switch sequence is widely expressed in tumors.

G N Marchenko1, A Y Strongin.   

Abstract

We report the discovery, cloning, and characterization of a novel human matrix metalloproteinase (MMP-28) cDNA gene. The deduced 520-amino-acid sequence of MMP-28 includes a signal peptide, a prodomain with an unusual cysteine-switch PRCGVTD motif followed by the furin cleavage RRKKR site, a catalytic domain, a hinge-region and a hemopexin-like domain. On the basis of their structural characteristics, MMP-28 belongs to the MMP-19 subfamily. The genomic MMP-28 gene uniquely mapped to chromosome 17q11.2 includes eight exons and seven introns. The broad range of expression in carcinomas as well as normal adult and fetal tissues suggests an important functional role for MMP-28.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11255011     DOI: 10.1016/s0378-1119(01)00360-2

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  46 in total

Review 1.  Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.

Authors:  Klaus Maskos; Wolfram Bode
Journal:  Mol Biotechnol       Date:  2003-11       Impact factor: 2.695

Review 2.  MMPs and TIMPs--an historical perspective.

Authors:  J Frederick Woessner
Journal:  Mol Biotechnol       Date:  2002-09       Impact factor: 2.695

Review 3.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

Review 4.  Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2007-07-07       Impact factor: 5.858

Review 5.  Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted.

Authors:  Kendra J Greenlee; Zena Werb; Farrah Kheradmand
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

Review 6.  Matrix metalloproteinase control of capillary morphogenesis.

Authors:  Cyrus M Ghajar; Steven C George; Andrew J Putnam
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2008       Impact factor: 1.807

Review 7.  Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.

Authors:  Jie Liu; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-05-10       Impact factor: 3.622

Review 8.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

9.  Mechanical strain activates a program of genes functionally involved in paracrine signaling of angiogenesis.

Authors:  Ru Yang; Jawaria Amir; Haibo Liu; Brahim Chaqour
Journal:  Physiol Genomics       Date:  2008-10-14       Impact factor: 3.107

10.  Expression and function of matrix metalloproteinase (MMP)-28.

Authors:  Ursula R Rodgers; Lara Kevorkian; Alison K Surridge; Jasmine G Waters; Tracey E Swingler; Kirsty Culley; Sara Illman; Jouko Lohi; Andrew E Parker; Ian M Clark
Journal:  Matrix Biol       Date:  2009-04-16       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.